Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Twist1 in podocytes ameliorates podocyte injury and proteinuria by limiting CCL2-dependent macrophage infiltration
Jiafa Ren, … , Robert F. Spurney, Steven D. Crowley
Jiafa Ren, … , Robert F. Spurney, Steven D. Crowley
Published August 9, 2021
Citation Information: JCI Insight. 2021;6(15):e148109. https://doi.org/10.1172/jci.insight.148109.
View: Text | PDF
Research Article Nephrology

Twist1 in podocytes ameliorates podocyte injury and proteinuria by limiting CCL2-dependent macrophage infiltration

  • Text
  • PDF
Abstract

The transcription factor Twist1 regulates several processes that could impact kidney disease progression, including epithelial cell differentiation and inflammatory cytokine induction. Podocytes are specialized epithelia that exhibit features of immune cells and could therefore mediate unique effects of Twist1 on glomerular disease. To study Twist1 functions in podocytes during proteinuric kidney disease, we employed a conditional mutant mouse in which Twist1 was selectively ablated in podocytes (Twist1-PKO). Deletion of Twist1 in podocytes augmented proteinuria, podocyte injury, and foot process effacement in glomerular injury models. Twist1 in podocytes constrained renal accumulation of monocytes/macrophages and glomerular expression of CCL2 and the macrophage cytokine TNF-α after injury. Deletion of TNF-α selectively from podocytes had no impact on the progression of proteinuric nephropathy. By contrast, the inhibition of CCL2 abrogated the exaggeration in proteinuria and podocyte injury accruing from podocyte Twist1 deletion. Collectively, Twist1 in podocytes mitigated urine albumin excretion and podocyte injury in proteinuric kidney diseases by limiting CCL2 induction that drove monocyte/macrophage infiltration into injured glomeruli. Myeloid cells, rather than podocytes, further promoted podocyte injury and glomerular disease by secreting TNF-α. These data highlight the capacity of Twist1 in the podocyte to mitigate glomerular injury by curtailing the local myeloid immune response.

Authors

Jiafa Ren, Yuemei Xu, Xiaohan Lu, Liming Wang, Shintaro Ide, Gentzon Hall, Tomokazu Souma, Jamie R. Privratsky, Robert F. Spurney, Steven D. Crowley

×

Figure 1

Induction of Twist1 in podocytes from patients with podocytopathies and mice with NTS- or ADR-induced glomerular disease.

Options: View larger image (or click on image) Download as PowerPoint
Induction of Twist1 in podocytes from patients with podocytopathies and ...
(A) Representative IHC staining of Twist1 in renal biopsies from patients with FSGS, IgA nephropathy, or DN or normal control subjects. Scale bar: 50 μm. (B and C) Twist1 mRNA (B) and protein abundance (C) in glomeruli isolated from mice on day 9 after NTS-induced glomerulonephritis (n = 3–7, Wilcoxon’s test). (D) Semiquantitative determination of Twist1 protein from blots in C (n = 3, t test). (E) Representative Twist1- and nephrin-costained kidney sections from vehicle- and NTS-treated animals. (F and G) Twist1 mRNA (F) and protein abundance (G) in glomeruli isolated from mice on day 4 after ADR-induced glomerular injury (n = 3–7, Wilcoxon’s test). (H) Semiquantitative determination of Twist1 protein from blots in G (n = 3, t test). (I) Representative Twist1- and nephrin-costained kidney sections from vehicle- and ADR-treated mice. Scale bar: 40 μm. Data represent mean ± SEM. All t tests were 2 tailed. *P < 0.05. veh, vehicle; NTS, nephrotoxic serum; ADR, adriamycin; FSGS, focal segmental glomerulosclerosis; DN, diabetic nephropathy.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts